Yamasaki S - Search Results

1

Immune suppression and reversal of the suppressive tumor microenvironment.

Shimizu K, Iyoda T, Okada M, Yamasaki S, Fujii SI. Shimizu K, et al. Among authors: yamasaki s. Int Immunol. 2018 Sep 25;30(10):445-454. doi: 10.1093/intimm/dxy042. Int Immunol. 2018. PMID: 29939325 Review.

2

KLRG+ invariant natural killer T cells are long-lived effectors.

Shimizu K, Sato Y, Shinga J, Watanabe T, Endo T, Asakura M, Yamasaki S, Kawahara K, Kinjo Y, Kitamura H, Watarai H, Ishii Y, Tsuji M, Taniguchi M, Ohara O, Fujii S. Shimizu K, et al. Among authors: yamasaki s. Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12474-9. doi: 10.1073/pnas.1406240111. Epub 2014 Aug 12. Proc Natl Acad Sci U S A. 2014. PMID: 25118276 Free PMC article.

3

Characterization of the myeloid-derived suppressor cell subset regulated by NK cells in malignant lymphoma.

Sato Y, Shimizu K, Shinga J, Hidaka M, Kawano F, Kakimi K, Yamasaki S, Asakura M, Fujii SI. Sato Y, et al. Among authors: yamasaki s. Oncoimmunology. 2015 Jan 22;4(3):e995541. doi: 10.1080/2162402X.2014.995541. eCollection 2015 Mar. Oncoimmunology. 2015. PMID: 25949922 Free PMC article.

4

Transfer of mRNA Encoding Invariant NKT Cell Receptors Imparts Glycolipid Specific Responses to T Cells and γδT Cells.

Shimizu K, Shinga J, Yamasaki S, Kawamura M, Dörrie J, Schaft N, Sato Y, Iyoda T, Fujii S. Shimizu K, et al. Among authors: yamasaki s. PLoS One. 2015 Jun 29;10(6):e0131477. doi: 10.1371/journal.pone.0131477. eCollection 2015. PLoS One. 2015. PMID: 26121617 Free PMC article.

5

Systemic DC Activation Modulates the Tumor Microenvironment and Shapes the Long-Lived Tumor-Specific Memory Mediated by CD8+ T Cells.

Shimizu K, Yamasaki S, Shinga J, Sato Y, Watanabe T, Ohara O, Kuzushima K, Yagita H, Komuro Y, Asakura M, Fujii S. Shimizu K, et al. Among authors: yamasaki s. Cancer Res. 2016 Jul 1;76(13):3756-66. doi: 10.1158/0008-5472.CAN-15-3219. Cancer Res. 2016. PMID: 27371739

6

In vivo dendritic cell targeting cellular vaccine induces CD4⁺ Tfh cell-dependent antibody against influenza virus.

Yamasaki S, Shimizu K, Kometani K, Sakurai M, Kawamura M, Fujii SI. Yamasaki S, et al. Sci Rep. 2016 Oct 14;6:35173. doi: 10.1038/srep35173. Sci Rep. 2016. PMID: 27739478 Free PMC article.

7

Amelioration of NK cell function driven by Vα24⁺ invariant NKT cell activation in multiple myeloma.

Iyoda T, Yamasaki S, Hidaka M, Kawano F, Abe Y, Suzuki K, Kadowaki N, Shimizu K, Fujii SI. Iyoda T, et al. Among authors: yamasaki s. Clin Immunol. 2018 Feb;187:76-84. doi: 10.1016/j.clim.2017.10.007. Epub 2017 Oct 20. Clin Immunol. 2018. PMID: 29061445

8

Vaccine Designs Utilizing Invariant NKT-Licensed Antigen-Presenting Cells Provide NKT or T Cell Help for B Cell Responses.

Fujii SI, Yamasaki S, Sato Y, Shimizu K. Fujii SI, et al. Among authors: yamasaki s. Front Immunol. 2018 Jun 4;9:1267. doi: 10.3389/fimmu.2018.01267. eCollection 2018. Front Immunol. 2018. PMID: 29915600 Free PMC article. Review.

9

Optimal therapeutic strategy using antigen-containing liposomes selectively delivered to antigen-presenting cells.

Iyoda T, Yamasaki S, Kawamura M, Ueda M, Son K, Ito Y, Shimizu K, Fujii SI. Iyoda T, et al. Among authors: yamasaki s. Cancer Sci. 2019 Mar;110(3):875-887. doi: 10.1111/cas.13934. Epub 2019 Feb 16. Cancer Sci. 2019. PMID: 30629329 Free PMC article.

10

Granzyme A Stimulates pDCs to Promote Adaptive Immunity via Induction of Type I IFN.

Shimizu K, Yamasaki S, Sakurai M, Yumoto N, Ikeda M, Mishima-Tsumagari C, Kukimoto-Niino M, Watanabe T, Kawamura M, Shirouzu M, Fujii SI. Shimizu K, et al. Among authors: yamasaki s. Front Immunol. 2019 Jun 26;10:1450. doi: 10.3389/fimmu.2019.01450. eCollection 2019. Front Immunol. 2019. PMID: 31293597 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,664 results

Search Page